z-logo
open-access-imgOpen Access
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates
Author(s) -
SoHee Hong,
Hanseul Oh,
Yong Wook Park,
Hye Won Kwak,
Eun Young Oh,
HyoJung Park,
KyungWon Kang,
Green Kim,
BonSang Koo,
Eunha Hwang,
Seung Ho Baek,
Hyeong-Jun Park,
YuSun Lee,
YooJin Bang,
Jaeyong Kim,
SeoHyeon Bae,
Su Jeen Lee,
Ki-Weon Seo,
Hak Kim,
Taewoo Kwon,
Ji Hwan Kim,
Seonghwan Lee,
Eunsom Kim,
YeonHwa Kim,
JaeHak Park,
SangIn Park,
Marta Gonçalves,
Byung Mook Weon,
Haengdueng Jeong,
Ki Taek Nam,
Kyung-Ah Hwang,
Jihye Kim,
Hun Kim,
SangMyeong Lee,
Jung Joo Hong,
Jae-Hwan Nam
Publication year - 2021
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abg7156
Subject(s) - immunization , virology , alum , antibody , coronavirus , toxoid , immunology , tetanus , biology , covid-19 , neutralizing antibody , severe acute respiratory syndrome coronavirus , neutralization , medicine , vaccination , chemistry , disease , pathology , infectious disease (medical specialty) , organic chemistry
A previously unknown SARS-CoV-2 vaccine protecting nonhuman primates from SARS-CoV-2 challenge was developed using RBD-P2 and N.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom